The Defymed team in pink and mobilized for Pink October. 🎗👚 1 woman in 8 is at risk of developing breast cancer. This is why prevention, screening and research are the keys to the fight against breast cancer. Together, all united against cancer ! #cancerdusein #OctobreRose

Read the interview of @Séverine SIGRIST by @Anaïs Thibaux for the health section of the Journal des Femmes. sante.journaldesfemmes.fr/fiches-maladie… #diabetes #T1D #ArtificialPancreas

Today marks the beginning of #DiabetesAwarenessMonth, the central motivation for our work. We begin this month of diabetes awareness with a history of the disease as knowledge comes power in diabetes prevention. watch the video : fb.watch/gxVo7dmvtL/ #diabetes #T1D

Yesterday, Defymed had the opportunity to participate in the #DMInnov event organized by MedUniq Center at IrcadFrance. linkedin.com/posts/meduniqc… #medicaldevices #innovation #ExOlin #MailPan

Today, the 11/14 is #WorldDiabetesAwarenessDay. This year to be part of this movement to raise awareness of what life is like for people living with diabetes we joined the #blueballoonchallenge. #T1D #diabetes linkedin.com/posts/defymed_…

In the continuation of the #DiabetesAwarenessMonth, our team has imagined a short comic strip depicting the diabetic patient's burden. Because yes, diabetes can represent a real mental load.We invite you all to keep in mind what this can represent to patients. #diabetes #T1D

Today, November 29, our team is attending the @BIOFIT_EVENT in Strasbourg. #BioFIT2022 #innovation #ExOlin #MailPan

Last week, our team had the chance to attend the Challenge Award Innovation ceremony organised by the @Diabetes Center Berne. Special focus on the inspiring keynote given by Jack Trigger, a solo sailor with T1D and a role model for overcoming diabetes which has never limited him

This month again, Defymed took part in the writing of the second ASDIAB'ACTU newsletter, recently produced by ASDIA. Enjoy your reading! lnkd.in/d5rz6xWN #diabetes #newsletter #patientinformation #bioartificialpancreas

With our fantastic christmas sweaters, all the #DefyTEAM and our mascot #Teddy wishes you happy holidays and many good wishes for a new year of happiness and prosperity to your family, friends, and colleagues.

The whole #Defyteam wishes you a happy new year 2023 🎉 The year 2022 has been rich and rewarding for @Defymed ! #bestwishes #innovation #medicaldevices #ExOlin #MailPan

On the 6th of January, the European Commission published a proposal to postpone the entry into force of the European Regulation 2017/745. We are currently awaiting the adoption of this proposal by the European Parliament and by the Council of Europe. lnkd.in/eZPwARBZ #MDR

What motivates you to get up in the morning? At Defymed it seems that everyone has the same #Defyspirit as the biggest motivations are : - the meaning found in our innovations - the challenge - the team spirit - and ... last but not least the beautiful view from our offices!

Do you know the members of our scientific board? Composed of specialists with diverse and complementary skills, this board supports and reinforces Defymed in its scientific approach and in the development of our devices. defymed.com/job_type/scien… #Innovation #scientificboard

Richard and Manuel will be at Advanced Technologies & Treatments for Diabetes. This will be a very good moment to meet our past, current and future partners. We will also be on booth 65A to present our #ExOlin and #MailPan to the world of diabetes. defymed.com/defymed-at-att…

On the 11th February, we celebrated the International Day of Women in Science. This day aims to promote the full and equal access and participation of women in science. According to UNESCO, less than 30% of the world's researchers are women. #InternationalDayOfWomenInScience

Week-1 ! Next week, from the 22nd to the 25th of February, Richard and Manuel will be attending the Advanced Technologies & Treatments for Diabetes in Berlin. bit.ly/3InVgkk At this occasion a little Throwback to ATTD 2022 #ATTD2023 #MyATTD #diabetescare #innovation #ExOlin #MailPan

D-Day! Richard BOUAOUN and Manuel Pires are in Berlin, ready to join the ATTD (Advanced Technologies & Treatments for Diabetes) meeting! Meet us on on the International Fair of New Technologies in Diabetes booth #65A #ATTD2023 #MyATTD #diabetescare #innovation

Last week Statice, ICPEES and Defymed met to exchange on the DECAPES project. This project is running for 3 years with this meeting marking the halfway point of this journey. It was the opportunity to report on the great progress made by this consortium. lnkd.in/gyVdbpiR

We are thrilled to celebrate the 12th birthday of Defymed, a company that has had 12 wonderful years of research and innovation thanks to our cohesive and dedicated team. We work tirelessly towards our common goal of striving for the patient's well-being. #defyteam #innovation